Skip to main content
Clinical Trials/NCT06058897
NCT06058897Active, not recruitingNot Applicable

Cerebral MRI Markers and Oculomotor Indices in Human Ageing: Potential Predictors of Cognitive Maintenance or Decline

University Hospital, Toulouse1 site in 1 country100 target enrollmentStarted: March 22, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
100
Locations
1
Primary Endpoint
Imaging contrast between the LC nucleus and the pontine tegmentum region

Study Overview

Brief Summary

This research proposes to investigate physiological and cognitive markers of locus coeruleus (LC) neuronal integrity and function in cognitively-healthy participants over 60 years old. The locus coeruleus is a brainstem nucleus, sole source of noradrenaline for the brain. Tau pathology appears in neurons of this nucleus, which may induce initial cognitive changes. The study aims at relating locus coeruleus markers, assessed with MRI and eye-tracking techniques, with cognitive function.

Detailed Description

The LC is a small brainstem nucleus, sole source of noradrenaline (NA) to the brain. NA is involved in the physiological arousal response: LC neuronal activity is closely related with pupil dilation, and pupil size is now considered a reliable and easy-access biomarker of LC function. NA-dependent cognitive functions include attention, flexibility and memory, which are selectively impaired with age. Accordingly, LC-NA system dysfunction may occur and contribute to initial cognitive changes during old age.

The study will assess, in cognitively-healthy older volunteers from the INSPIRE cohort (n=100, over 60 years old), MRI and pupillometry markers of LC integrity, LC-forebrain connectivity and LC activity. We aim at investigating the relationship between LC biomarkers and cognitive status. Four experimental visits will be conducted by each participant, every 6 months over an 18-month period. Visits V1 and V4 will include MRI, eye-tracking and detailed cognitive exams. Visits V2 and V3 will include a detailed cognitive exam.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
60 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •INSPIRE cohort participant
  • •Mini-Mental State Examination score ≥ 27 on 30
  • •Access to a web connection from participant's or relative's home and regular use of web surfing
  • •Signature of the informed consent
  • •Affiliated to a social security scheme

Exclusion Criteria

  • •Any contra-indications to MRI exam
  • •Ophthalmic pathology impacting eye-tracking measures
  • •Neurological or psychiatric pathology
  • •Person under guardianship or curatorship
  • •Contraindications to MRI examination:
  • •Pacemaker or cardiac defibrillator
  • •Implanted material activated by an electrical, magnetic or mechanical system
  • •Haemostatic clips for intracerebral aneurysms or carotid arteries
  • •Orthopedic implants
  • •Claustrophobia
  • •Ophthalmological pathologies impacting eye tracking measurements:
  • •Age-related macular degeneration
  • •Unoperated cataract

Arms & Interventions

Experimental

Experimental

MRI, eye-tracking and cognitive exams will be completed by subjects.

Intervention: cognitive exams (Other)

Experimental

Experimental

MRI, eye-tracking and cognitive exams will be completed by subjects.

Intervention: MRI (Other)

Experimental

Experimental

MRI, eye-tracking and cognitive exams will be completed by subjects.

Intervention: eye-tracking (Other)

Outcomes

Primary Outcomes

Imaging contrast between the LC nucleus and the pontine tegmentum region

Time Frame: 18 months

The outcome will be measured with brainstem anatomical MRI (no unit) at visits V1 (immediately after inclusion) and V4 (18 months after inclusion).

Secondary Outcomes

  • Z-score of the LC-forebrain connectivity at rest(18 months)
  • Amplitude of the phasic pupil response during completion of cognitive tasks(18 months)
  • Latency of saccadic eye movements during completion of cognitive tasks(18 months)
  • Amplitude of saccadic eye movements during completion of cognitive tasks(18 months)
  • Composite cognitive (executive and memory) score(18 months)
  • Levels of blood phospho-Tau(18 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials